ZBIO

Zenas BioPharma, Inc. Common Stock
ZBIO

Overview Fund Activity

65 hedge funds and large institutions have $260M invested in Zenas BioPharma, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+22
Holders Change %
+51.16%
% of All Funds
0.87%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
36
Increased
13
Reduced
6
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
$8.24M
2
Vanguard Group
Vanguard Group
Pennsylvania
$8.02M
3
NHAS
Novo Holdings A/S
Denmark
$13.1M
4
ACH
ArrowMark Colorado Holdings
Colorado
$5.14M
5
Geode Capital Management
Geode Capital Management
Massachusetts
$2.86M

Top Sellers

1
PA
Perceptive Advisors
New York
$6.09M
2
Wellington Management Group
Wellington Management Group
Massachusetts
$9.17M
3
MIM
Monashee Investment Management
Massachusetts
$0
4
Fidelity Investments
Fidelity Investments
Massachusetts
$14.6M
5
Aberdeen Group
Aberdeen Group
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CM
76
Capula Management
Cayman Islands
– -$180K -10,615 Closed
LCM
77
Landscape Capital Management
New Jersey
– -$170K -10,074 Closed
CSS
78
Cubist Systematic Strategies
Connecticut
– -$63.7K -3,762 Closed
ACM
79
Aster Capital Management
United Arab Emirates
– -$51.1K -3,018 Closed
1 2 3
4